# A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

> **NCT00121017** · PHASE2 · WITHDRAWN · sponsor: **Abbott** · enrollment: 200 (—)

## Conditions studied

- HIV Infection
- Hepatitis C

## Interventions

- **DRUG:** Kaletra (lopinavir/ritonavir)
- **DRUG:** Sustiva (efavirenz)
- **DRUG:** Truvada (emtricitabine/tenofovir disoproxil fumarate)

## Key facts

- **NCT ID:** NCT00121017
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121017, "A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00121017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*